Aerosol vs smoke: two terms often used interchangeably, but they’re not the same. Hear from our Director External Scientific Assessment, Non-Clinical Science as he explains the difference, grounded in scientific evidence 👇

Science makes a difference when it’s communicated clearly. In this episode of My Life in Science, meet Jessica, a neuroscientist by training who now helps translate complex research into engaging stories that others can read, question, and build on.

Meet Helene, a Plant Testing Manager based at PMI’s greenhouse facility in Onnens, Switzerland. In this installment of My Life in Science, she shares her 18-year journey, what first inspired her to pursue a career in science, and what continues to motivate her today.

What is combustion, and why does it matter? Our Head of Combustion and Aerosol Science talks us through it. Sound on! 🔉

This week, we’ll be at the @GFNicotine in Warsaw for #GFN26. In this short teaser, our VP External Scientific Affairs, @GizelleBaker, and our Chief Medical Officer, Tryggve Ljung, preview one of the conversations we’ll be continuing at the conference: how evidence from longer-established product categories can inform discussions around newer ones 👇

Behind every study, every breakthrough, there are people driven by curiosity and purpose. Get to know our scientific community in our new series, My Life in Science. In this first episode, meet Tanja as she shares her journey from postdoc researcher to Senior Lab Scientist, and the key lessons she’s learned along the way.

As new tobacco and nicotine alternatives continue to be introduced, regulatory frameworks need to evolve just as quickly to reflect the latest scientific evidence. Around the world, some governments are beginning to recognize that science-based, differentiated regulations can better support adults who smoke by giving them access to scientifically substantiated alternatives. For more on the regulatory overview on smoke-free products 👉 spr.ly/6013B6hvVF

Valuable research, like PMI Science’s, can’t make a difference if it’s shut out. We need to evaluate the science, not suppress it—every scientific voice matters.

Better decisions are only possible when people have clear and scientifically accurate facts that cut through confusion. Because misconceptions about smoke-free products persist, we’re committed to strengthening transparency by openly sharing key scientific facts and figures behind our progress.

Behind our smoke-free vision is a diverse team of over 1,400 specialists dedicated to improving the way science serves society. At PMI Science, our community brings together a broad range of disciplines and collective expertise to advance our scientific research and drive meaningful innovation 👇

Misinformation can obscure scientific truth, creating false narratives that confuse the public and hinder the innovation needed for a better future. That’s why we continue to share our research findings and studies openly through resources like our PMI Science Booklet and Leaflet, reinforcing our commitment to transparency and integrity.

Through sharing our research openly, publishing peer-reviewed research, and continuously investing in innovation, we’re committed to turning data into dialogue and evidence into trust. This is what measurable progress looks like 👉 spr.ly/6017hdlWX

We’re proud of our extensive portfolio of patents, which reflects our ongoing investment in creating, scientifically substantiating, and commercializing smoke‑free products that offer adult smokers better alternatives to cigarettes. #SmokeFreeFuture #ResearchAndDevelopment

10 years of postmarket safety surveillance data. What have we learned? The 22nd issue of the Scientific Update showcases PMI’s commitment to monitor product safety after market release, highlighting the work of our safety surveillance team and sharing findings from the robust postmarket safety surveillance system established at PMI. Swipe to explore 👇

Sweden’s long-standing use of oral smokeless alternatives, like snus and more recently nicotine pouches, has contributed to the lowest smoking rate in Europe. This shift offers valuable insights for other countries exploring ways to reduce cigarette use. Discover the science and technology behind nicotine pouches here 👉 spr.ly/6010h3a2K #SwedishExperience #NicotinePouches #SmokeFreeFuture

What drives adult smokers to consider switching to smoke-free alternatives? We are using science to find the answers. Explore the full findings in our PMI Science Booklet: spr.ly/6017hyOC5 #PerceptionBehavior #RiskPerception #SmokeFreeAlternatives

Our goal is simple: to accelerate the end of smoking through science‑based innovation and transparent scientific communication. When science is open, progress is faster. Here’s more on some of the ways we make our research accessible, and encourage dialogue across the global scientific community👇

Majority of the toxicants in cigarette smoke originate from burning tobacco at high temperatures. By heating tobacco at low temperatures instead of burning it, our leading heated tobacco product emits an aerosol that contains significantly fewer and lower levels of toxicants compared with cigarette smoke. Find out more about the difference between smoke and aerosol 👉 spr.ly/6013C4ShL #HeatedTobacco #SmokeVsAerosol

Dr. Fischer, Manager of Regulatory Consumer Research at PMI, leads postmarket studies on the role of heated tobacco products (HTPs) in harm reduction. Her research, including a 6-year study in Japan, explores how millions of adult smokers have transitioned from cigarettes to HTPs—contributing to a continued decline in smoking prevalence. For her interview in full to explore her research on tobacco harm reduction 👉 spr.ly/6016C9Mbe

At PMI, proactive monitoring of the safety profile of our smoke-free products and strict regulatory compliance is paramount. Our robust postmarket safety surveillance framework ensures that this is upheld throughout the entire product lifecycle. More on our approach 👉 spr.ly/6012C3mrI